| Date Filed | Type | Description |
| 08/16/2023 |
4
| Pauls Matthew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $4.6, valued at
$69k
|
|
| 08/16/2023 |
3
| Pauls Matthew (Director) has filed a Form 3 on SOLENO THERAPEUTICS INC |
| 12/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Pauls Matthew (CEO) has filed a Form 4 on Savara Inc|
Txns:
| Paid exercise price by delivering 62,318 shares
@ $1.24, valued at
$77.3k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Pauls Matthew (CEO) has filed a Form 4 on Savara Inc|
Txns:
| Bought 10,000 shares
@ $1.1, valued at
$11k
Bought 10,000 shares
@ $1.11, valued at
$11.1k
Bought 2,150 shares
@ $1.065, valued at
$2.3k
|
|
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Pauls Matthew (CEO) has filed a Form 4 on Savara Inc|
Txns:
| Granted 500,000 options to buy
@ $1.23, valued at
$615k
|
|
| 09/15/2020 |
4
| Pauls Matthew (See Remarks) has filed a Form 4 on Savara Inc|
Txns:
| Granted 227,272 shares
@ $0
Exercised 650 restricted stock units
@ $0
Granted 898,639 options to buy
@ $1.32, valued at
$1.2M
|
|
| 05/21/2020 |
4
| Pauls Matthew (Director) has filed a Form 4 on Zyla Life Sciences|
Txns:
| Disposed/sold 26,953 shares
@ $0 |
|
| 04/28/2020 |
4/A
| Pauls Matthew (Director) has filed a Form 4 on Zyla Life Sciences|
Txns:
| Exercised 6,667 shares
@ $1.75, valued at
$11.7k
Paid exercise price by delivering 1,805 shares
@ $1.75, valued at
$3.2k
Exercised 6,667 restricted stock units
@ $0 |
|
| 04/24/2020 |
4
| Pauls Matthew (Director) has filed a Form 4 on Zyla Life Sciences|
Txns:
| Exercised 6,667 shares
@ $1.75, valued at
$11.7k
Paid exercise price by delivering 952 shares
@ $1.75, valued at
$1.7k
Exercised 6,667 restricted stock units
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2019 |
4
| Pauls Matthew (Director) has filed a Form 4 on Egalet Corp|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/14/2018 |
4
| Pauls Matthew (Director) has filed a Form 4 on Savara Inc|
Txns:
| Granted 12,000 options to buy
@ $7.33, valued at
$88k
|
|
| 02/28/2018 |
4
| Pauls Matthew (President & CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,392 shares
@ $6.6, valued at
$114.8k
|
|
| 02/06/2018 |
4
| Pauls Matthew (President & CEO) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 350,000 options to buy
@ $6.65, valued at
$2.3M
|
|
| 01/02/2018 |
3
| Pauls Matthew (President & CEO) has filed a Form 3 on Strongbridge Biopharma plc |
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/02/2015 |
4
| Pauls Matthew (Director) has filed a Form 4 on Mast Therapeutics, Inc.|
Txns:
| Granted 64,791 options to buy
@ $0.48, valued at
$31.1k
Granted 37,794 options to buy
@ $0.48, valued at
$18.1k
|
|
| 06/04/2014 |
4
| Pauls Matthew (Chief Commercial Officer) has filed a Form 4 on INSMED INC|
Txns:
| Granted 30,000 options
@ $12.58, valued at
$377.4k
|
|
| 01/14/2014 |
4
| Pauls Matthew (Chief Commercial Officer) has filed a Form 4 on INSMED INC|
Txns:
| Granted 30,000 options
@ $20.49, valued at
$614.7k
|
|
| 05/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |